March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
April 10, 2023
The University of Cincinnati's Kelly Dobos walked the Wall Street Journal through ingredients in a commercially available foundation from a "clean beauty" brand.
April 7, 2023
Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.
May 2, 2023
University of Cincinnati cosmetic science expert Kelly Dobos was featured in a Vox article providing clarity on common questions about sunscreen.
May 3, 2023
The University of Cincinnati's Cosmetic Science program will launch a graduate certificate in hygienic manufacturing of cosmetic products beginning this fall.
April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
October 19, 2023
The University of Cincinnati’s Timothy Phoenix is one of the investigators on a research team that is part of a new NCI Pediatric Immunotherapy Network and studying how to improve immunotherapy treatments for pediatric brain tumors.
January 31, 2023
The University of Cincinnati's Kelly Epplen discussed trends in pharmacy school enrollment with Local 12 following announcements that CVS and Walmart pharmacies would be cutting back on hours.
September 8, 2022
Radio show and podcast Sunday Morning Magazine featured the Klaserner family of parents John and Lorrie, UC pharmacy alumni, and children Adam and Ally, current students at UC's James L. Winkle College of Pharmacy.
December 4, 2023
The University of Cincinnati's Rowena Schwartz joined The Oncology Nursing Podcast to discuss what oncology nurses need to know about a class of drugs called antimetabolites.